|
|
| | LSP-249 Basic information |
| Product Name: | LSP-249 | | Synonyms: | LSP-249;4-Pyridinecarboxamide, N-[(6-amino-2,4-dimethyl-3-pyridinyl)methyl]-2-[(3-chloro-6-quinolinyl)methyl]-;N-[(6-Amino-2,4-dimethyl-3-pyridinyl)methyl]-2-[(3-chloro-6-quinolinyl)methyl]-4-pyridinecarboxamide;inhibit,LSP-249,Serine proteases,Inhibitor,angioedema,LSP249,Ser/Thr Protease,Serine endopeptidases,Threonine proteases,LSP 249 | | CAS: | 1801253-04-2 | | MF: | C24H22ClN5O | | MW: | 431.92 | | EINECS: | | | Product Categories: | | | Mol File: | 1801253-04-2.mol |  |
| | LSP-249 Chemical Properties |
| form | Solid | | color | White to light yellow |
| | LSP-249 Usage And Synthesis |
| Description | LSP-249 is a plasma kallikrein inhibitor for treatment of angioedema. |
| | LSP-249 Preparation Products And Raw materials |
|